PubRank

Niels van Royen

Author PubWeight™ 34.97‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Noninvasive imaging of angiogenesis with a 99mTc-labeled peptide targeted at alphavbeta3 integrin after murine hindlimb ischemia. Circulation 2005 1.81
2 Prevalence and impact of a chronic total occlusion in a non-infarct-related artery on long-term mortality in diabetic patients with ST elevation myocardial infarction. Heart 2010 1.49
3 Forkhead box protein P1 as a downstream target of transforming growth factor-β induces collagen synthesis and correlates with a more stable plaque phenotype. Atherosclerosis 2011 1.48
4 Arteriogenesis depends on circulating monocytes and macrophage accumulation and is severely depressed in op/op mice. J Leukoc Biol 2006 1.48
5 Differential expression of GAPDH and beta3-actin in growing collateral arteries. Mol Cell Biochem 2002 1.45
6 Effect of additional treatment with EXenatide in patients with an Acute Myocardial Infarction: the EXAMI study. Int J Cardiol 2012 1.41
7 Interferon-beta signaling is enhanced in patients with insufficient coronary collateral artery development and inhibits arteriogenesis in mice. Circ Res 2008 1.32
8 Direct evidence for tumor necrosis factor-alpha signaling in arteriogenesis. Circulation 2002 1.19
9 Arteriogenesis proceeds via ICAM-1/Mac-1- mediated mechanisms. Circ Res 2004 1.18
10 Modulation of collateral artery growth in a porcine hindlimb ligation model using MCP-1. Am J Physiol Heart Circ Physiol 2002 1.16
11 Magnetic resonance imaging-defined areas of microvascular obstruction after acute myocardial infarction represent microvascular destruction and haemorrhage. Eur Heart J 2013 1.11
12 Galectin-2 expression is dependent on the rs7291467 polymorphism and acts as an inhibitor of arteriogenesis. Eur Heart J 2011 1.10
13 Abnormal monocyte recruitment and collateral artery formation in monocyte chemoattractant protein-1 deficient mice. Vasc Med 2004 1.08
14 Targeting angiogenesis to restore the microcirculation after reperfused MI. Nat Rev Cardiol 2009 1.05
15 Leukocyte subpopulations and arteriogenesis: specific role of monocytes, lymphocytes and granulocytes. Atherosclerosis 2005 1.00
16 Suppression of inflammatory signaling in monocytes from patients with coronary artery disease. J Mol Cell Cardiol 2008 0.98
17 Anti-tumor necrosis factor-{alpha} therapies attenuate adaptive arteriogenesis in the rabbit. Am J Physiol Heart Circ Physiol 2005 0.93
18 Acute haemodynamic effects of accelerated idioventricular rhythm in primary percutaneous coronary intervention. EuroIntervention 2011 0.92
19 Blocking interferon {beta} stimulates vascular smooth muscle cell proliferation and arteriogenesis. J Biol Chem 2010 0.87
20 Local cytokine concentrations and oxygen pressure are related to maturation of the collateral circulation in humans. J Am Coll Cardiol 2009 0.87
21 Aspirin, but not clopidogrel, reduces collateral conductance in a rabbit model of femoral artery occlusion. J Am Coll Cardiol 2005 0.86
22 Evaluating the optimal timing of revascularisation in patients with transient ST-segment elevation myocardial infarction: rationale and design of the TRANSIENT Trial. J Cardiovasc Transl Res 2014 0.86
23 Differential effects of MCP-1 and leptin on collateral flow and arteriogenesis. Cardiovasc Res 2004 0.86
24 The coronary collateral circulation: genetic and environmental determinants in experimental models and humans. J Mol Cell Cardiol 2011 0.85
25 Experimental models of arteriogenesis: differences and implications. Lab Anim (NY) 2006 0.82
26 Endothelial glycocalyx dimensions are reduced in growing collateral arteries and modulate leucocyte adhesion in arteriogenesis. J Cell Mol Med 2009 0.82
27 A new intra-arterial delivery platform for pro-arteriogenic compounds to stimulate collateral artery growth via transforming growth factor-beta1 release. J Am Coll Cardiol 2007 0.81
28 Invasive measurement of coronary microvascular resistance in patients with acute myocardial infarction treated by primary PCI. Heart 2013 0.81
29 Granulocyte-macrophage colony-stimulating factor stimulates arteriogenesis in a pig model of peripheral artery disease using clinically applicable infusion pumps. J Vasc Surg 2006 0.80
30 Effect of additional treatment with EXenatide in patients with an Acute Myocardial Infarction (EXAMI): study protocol for a randomized controlled trial. Trials 2011 0.80
31 Effect of cardiac hybrid ¹⁵O-water PET/CT imaging on downstream referral for invasive coronary angiography and revascularization rate. Eur Heart J Cardiovasc Imaging 2013 0.80
32 Invasive and non-invasive evaluation of spontaneous arteriogenesis in a novel porcine model for peripheral arterial obstructive disease. Atherosclerosis 2003 0.78
33 Stimulation of collateral artery growth: a potential treatment for peripheral artery disease. Expert Rev Cardiovasc Ther 2004 0.77
34 Endothelial dysfunction and the occurrence of radial artery spasm during transradial coronary procedures: the ACRA-Spasm study. EuroIntervention 2016 0.76
35 Expression of a retinoic acid signature in circulating CD34 cells from coronary artery disease patients. BMC Genomics 2010 0.76
36 The long-term effect of transradial coronary catheterisation on upper limb function. EuroIntervention 2017 0.75
37 Evaluation of myocardial blood flow and coronary flow reserve after implantation of a bioresorbable vascular scaffold versus metal drug-eluting stent: an interim one-month analysis of the VANISH trial. EuroIntervention 2016 0.75
38 Instantaneous wave-free ratio to guide coronary revascularization: physiological framework, validation and differences with fractional flow reserve. EuroIntervention 2017 0.75
39 Effects of Successful Percutaneous Coronary Intervention of Chronic Total Occlusions on Myocardial Perfusion and Left Ventricular Function. EuroIntervention 2017 0.75
40 Noninvasive assessment of the collateral circulation in the hand, validation of the Nexfin system and relation to clinical outcome after transradial catheterization. EuroIntervention 2016 0.75
41 Distinct CD44 splice variants differentially affect collateral artery growth. Curr Vasc Pharmacol 2013 0.75